Preformed EPC Plain Liposomes with 33 mol% CHOL

<strong>Preformed EPC Plain Liposomes with 33 mol% CHOL </strong>_x000D_ <strong>Catalog number:</strong> B2019442_x000D_ <strong>Lot number:</strong> Batch Dependent_x000D_ <strong>Expiration Date:</strong> Batch dependent_x000D_ <strong>Amount:</strong> 5 mL_x000D_ <strong>Molecular Weight or Concentration:</strong> N/A_x000D_ <strong>Supplied as:</strong> Solution_x000D_ <strong>Applications:</strong> a molecular tool for various biochemical applications_x000D_ <strong>Storage:</strong> RT_x000D_ <strong>Keywords:</strong> Preformed EPC Plain Liposomes with 33 mol% CHOL_x000D_ <strong>Grade:</strong> Biotechnology grade. All products are highly pure. All solutions are made with Type I ultrapure water (resistivity &gt;18 MΩ-cm) and are filtered through 0.22 um._x000D_ _x000D_ <strong>References:</strong>_x000D_ 1: Steenpass T, Lung A, Schubert R. Tresylated PEG-sterols for coupling of proteins to preformed plain or PEGylated liposomes Biochim Biophys Acta. 2006 Jan;1758(1):20-8._x000D_ 2: Jarzynska K, Gajewicz-Skretna A, Ciura K, Puzyn T. Predicting zeta potential of liposomes from their structure: A nano-QSPR model for DOPE, DC-Chol, DOTAP, and EPC formulations Comput Struct Biotechnol J. 2024 Jan 24;25:3-8._x000D_ 3: Jeffs LB, Palmer LR, Ambegia EG, Giesbrecht C, Ewanick S, MacLachlan I. A scalable, extrusion-free method for efficient liposomal encapsulation of plasmid DNA Pharm Res. 2005 Mar;22(3):362-72._x000D_ 4: Aditya NP, Vathsala PG, Vieira V, Murthy RS, Souto EB. Advances in nanomedicines for malaria treatment Adv Colloid Interface Sci. 2013 Dec;201-202:1-17._x000D_ 5: van Elk M, van den Dikkenberg JB, Storm G, Hennink WE, Vermonden T, Heger M. Preclinical evaluation of thermosensitive poly(N-(2-hydroxypropyl) methacrylamide mono/dilactate)-grafted liposomes for cancer thermochemotherapy Int J Pharm. 2018 Oct 25;550(1-2):190-199._x000D_ 6: Zuidam NJ, Crommelin DJ. Chemical hydrolysis of phospholipids J Pharm Sci. 1995 Sep;84(9):1113-9._x000D_ 7: Parmentier J, Becker MM, Heintz U, Fricker G. Stability of liposomes containing bio-enhancers and tetraether lipids in simulated gastro-intestinal fluids Int J Pharm. 2011 Feb 28;405(1-2):210-7._x000D_ 8: Wang Z, Ling L, Du Y, Yao C, Li X. Reduction responsive liposomes based on paclitaxel-ss-lysophospholipid with high drug loading for intracellular delivery Int J Pharm. 2019 Jun 10;564:244-255._x000D_ 9: Li Y, Guan Q, Xu J, Zhang H, Liu S, Ding Z, Wang Q, Wang Z, Liu M, Zhao Y. Comparative study of cyclosporine A liposomes and emulsions for ophthalmic drug delivery: Process optimization through response surface methodology (RSM) and biocompatibility evaluation Colloids Surf B Biointerfaces. 2023 May;225:113267._x000D_ <a href="https://pubmed.ncbi.nlm.nih.gov/21125861">10: Zhai G, Wu J, Yu B, Guo C, Yang X, Lee RJ. A transferrin receptor-targeted liposomal formulation for docetaxel J Nanosci Nanotechnol. 2010 Aug;10(8):5129-36. </a>_x000D_ _x000D_ <strong>Products Related to Preformed EPC Plain Liposomes with 33 mol% CHOL can be found at</strong> <a href="https://moleculardepot.com/product-category/Chemicals/"> Chemicals</a>